WO2009089121A3 - Polypeptides d'hémagglutinine, réactifs, et procédés s'y rapportant - Google Patents

Polypeptides d'hémagglutinine, réactifs, et procédés s'y rapportant Download PDF

Info

Publication number
WO2009089121A3
WO2009089121A3 PCT/US2009/030058 US2009030058W WO2009089121A3 WO 2009089121 A3 WO2009089121 A3 WO 2009089121A3 US 2009030058 W US2009030058 W US 2009030058W WO 2009089121 A3 WO2009089121 A3 WO 2009089121A3
Authority
WO
WIPO (PCT)
Prior art keywords
reagents
methods relating
hemagglutinin polypeptides
polypeptides
bind
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2009/030058
Other languages
English (en)
Other versions
WO2009089121A2 (fr
Inventor
Ram Sasisekharan
Karthik Viswanathan
Aarthi Chandrasekaran
Rahul Raman
Aravind Srinivasan
S. Raguram
Viswanathan Sasisekharan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Massachusetts Institute of Technology
Original Assignee
Massachusetts Institute of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/969,040 external-priority patent/US20090081193A1/en
Application filed by Massachusetts Institute of Technology filed Critical Massachusetts Institute of Technology
Priority to EP09701014A priority Critical patent/EP2238146A4/fr
Priority to CA2711334A priority patent/CA2711334A1/fr
Publication of WO2009089121A2 publication Critical patent/WO2009089121A2/fr
Publication of WO2009089121A3 publication Critical patent/WO2009089121A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • C40B40/12—Libraries containing saccharides or polysaccharides, or derivatives thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/11—Orthomyxoviridae, e.g. influenza virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Oncology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La présente invention porte sur un système permettant d'analyser des interactions entre des glycanes et des partenaires d'interaction qui se lient à ceux-ci. La présente invention porte également sur des polypeptides HA qui se lient à des glycanes à topologie en parapluie, ainsi que sur des réactifs et des procédés s'y rapportant.
PCT/US2009/030058 2008-01-03 2009-01-02 Polypeptides d'hémagglutinine, réactifs, et procédés s'y rapportant Ceased WO2009089121A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP09701014A EP2238146A4 (fr) 2008-01-03 2009-01-02 Polypeptides d'hémagglutinine, réactifs, et procédés s'y rapportant
CA2711334A CA2711334A1 (fr) 2008-01-03 2009-01-02 Polypeptides d'hemagglutinine, reactifs, et procedes s'y rapportant

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US1878308P 2008-01-03 2008-01-03
US11/969,040 US20090081193A1 (en) 2006-08-14 2008-01-03 Hemagglutinin polypeptides, and reagents and methods relating thereto
US11/969,040 2008-01-03
US61/018,783 2008-01-03
US30112608A 2008-11-17 2008-11-17
US12/301,126 2008-11-17

Publications (2)

Publication Number Publication Date
WO2009089121A2 WO2009089121A2 (fr) 2009-07-16
WO2009089121A3 true WO2009089121A3 (fr) 2009-10-08

Family

ID=40853716

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2009/030058 Ceased WO2009089121A2 (fr) 2008-01-03 2009-01-02 Polypeptides d'hémagglutinine, réactifs, et procédés s'y rapportant

Country Status (3)

Country Link
EP (1) EP2238146A4 (fr)
CA (1) CA2711334A1 (fr)
WO (1) WO2009089121A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103328002B (zh) * 2010-10-04 2020-01-14 麻省理工学院 血球凝集素多肽以及与其相关的试剂和方法

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP3467A (en) 2007-10-16 2015-11-30 Peptimmune Inc Methods for designing and preparing vaccines comprising directed sequence polymer compositions via the directed expansion of epitopes
JP2013541528A (ja) 2010-09-21 2013-11-14 マサチューセッツ インスティテュート オブ テクノロジー ヒト適応ｈａポリペプチド、ワクチン、およびインフルエンザの処置
SG11201406769RA (en) 2012-05-10 2014-11-27 Massachusetts Inst Technology Agents for influenza neutralization
ES2991988T3 (es) 2017-10-30 2024-12-05 Takeda Pharmaceuticals Co Detergentes compatibles con el medio ambiente para la inactivación de virus con envoltura lipídica

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008073161A2 (fr) * 2006-08-14 2008-06-19 Massachusetts Institute Of Technology Polypeptides d'hémagglutinine, réactifs et procédés correspondants

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
GAMBLIN ET AL.: "The Structure and Receptor Binding Properties of the 1918 Influenza Hemagglutinin.", SCIENCE, vol. 303, 2004, pages 1838 - 1842, XP002445848 *
See also references of EP2238146A4 *
STEVENS ET AL.: "Glycan Microarray Analysis of the Hemagglutinins from Modem and Pandemic Influenza Viruses Reveals Different Receptor Specificities.", J. MOL. BIOL., vol. 355, 2006, pages 1143 - 155, XP024950637 *
TUMPEY ET AL.: "A Two Amino Acid Change in the Hemagglutinin of the 1918 Influenza Virus Abolishes Transmission.", SCIENCE, vol. 315, 2007, pages 655 - 659, XP008129180 *
YANG ET AL.: "Immunization by Avian H5 Influenza Hemagglutinin Mutants with Altered Receptor Binding Specificity.", SCIENCE, vol. 317, 2007, pages 825 - 828, XP002503152 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103328002B (zh) * 2010-10-04 2020-01-14 麻省理工学院 血球凝集素多肽以及与其相关的试剂和方法

Also Published As

Publication number Publication date
EP2238146A2 (fr) 2010-10-13
CA2711334A1 (fr) 2009-07-16
EP2238146A4 (fr) 2012-03-21
WO2009089121A2 (fr) 2009-07-16

Similar Documents

Publication Publication Date Title
WO2008073161A3 (fr) Polypeptides d'hémagglutinine, réactifs et procédés correspondants
WO2012047941A3 (fr) Polypeptides de l'hémagglutinine, et réactifs et procédés associés à ceux-ci
WO2009140039A3 (fr) Anticorps synthétiques
WO2008048970A3 (fr) Anticorps synthétiques
WO2009052400A8 (fr) Anticorps qui se lient à la ngal des mammifères et utilisations de ceux-ci
WO2009014787A3 (fr) Dosage de plusieurs analytes
GB2469962A (en) Automatic connections between application components
WO2014059442A3 (fr) Réactifs à base d'anticorps qui reconnaissent spécifiquement des formes oligomériques toxiques de tau
WO2008091954A3 (fr) Anticorps cd40 optimisés et leurs procédés d'utilisation
WO2011105695A3 (fr) Dispositif électronique et procédé de mise en fonctionnement d'un dispositif électronique
WO2009070243A3 (fr) Agents et épitopes de liaison à wise
WO2011044298A3 (fr) Systèmes et procédés pour établir une représentation environnementale
WO2010145792A8 (fr) Protéines bispécifiques se liant à un antigène
WO2008005321A3 (fr) Systèmes et procédés de réaction en chaîne de la polymérase en temps réel
HK1208284A1 (en) Deep-maldi tof mass spectrometry of complex biological samples, e.g., serum, and uses thereof
WO2010042284A3 (fr) Systèmes de commande microfluidique
EP2146207A4 (fr) Reactif de mesure, immunonephelemetrie l'utilisant et outil d'analyse d'analytes
WO2008070269A3 (fr) Procédés, logiciel et systèmes d'imagerie
WO2008048519A3 (fr) Anticorps se liant aux épitopes de cxcr7
WO2015075269A9 (fr) Anticorps dirigés contre ccr9 et leurs applications
MX2010002408A (es) Tapa para botella, ensamble de tapa y botella.
WO2010111299A3 (fr) Anticorps de synthèse
WO2011053565A3 (fr) Compositions et méthodes de détection d'une tauopathie
WO2009052221A3 (fr) Procédés d'extraction de plaquettes et compositions obtenues à partir de ceux-ci
WO2010079510A3 (fr) Anticorps monoclonaux anti-rhd

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09701014

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2711334

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2009701014

Country of ref document: EP